PUBLISHED ESOS EVIDENCE

GLENMARK PHARMACEUTICALS EUROPE LIMITED

Companies House number 05040260

Reported measures: 1
Action plans: 1
Progress updates: 1
Compliance records: 1

Reported energy-saving measures

Published evidence for this organisation includes Other reported measures. Complete records retain the original wording and provenance inside ESOS IQ.

Other reported measuresA later update says this measure was not yet completedReported implementation date: 01/12/2026

Official publication trail

Follow each available source route to check the published record in context.

Phase 3 Action Plan · published June 2026Action Plan · 14/08/2026
Open official source ↗
Phase 3 Progress Update 1 · published June 2026Progress Update · 14/08/2026
Open official source ↗
Phase 3 Compliance Notifications · published June 2026Compliance notification · 14/08/2026
Open official source ↗

Evidence boundary: these are participant-supplied declarations in public ESOS records. They are not proof of current procurement intent, implementation, compliance, budget or supplier need. Verify the official publication before acting.

Open the complete evidence trail

Inspect source wording, provenance, dates and later progress without losing the boundary between a published fact and an inference.

Preview evidence Create a free account →